share_log

Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor

Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor

全球大麻集團宣布傑夫·納格爾擔任產品製造顧問
newsfile ·  2023/03/30 09:33

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that Jeff Nagel has joined the Company's Advisory Board as its Product Manufacturing Advisor.

溫哥華, 不列顛哥倫比亞省---(新聞檔公司-3 月 30, 2023)-全球大麻集團有限公司(CSE: GHG) (場外粉紅色代碼:GBHPF) (FSE: GHG) (簡稱「溫室氣體」或「公司」) 欣然宣佈 Jeff Nagel 已加入公司顧問委員會擔任其產品製造顧問。

Mr. Nagel is a veteran in the natural biologics drug discovery and manufacturing space, with more than 15 years' experience in the industry. He brings with him a wealth of knowledge and expertise that will be invaluable to Global Hemp Group Inc. both as an advisor to the R&D Division in their ongoing development of various hemp-based products and technologies, as well assisting Management in their continuing discussions with various manufacturers and distributors in the sublicensing of its exclusive license of Patents and Intellectual Property acquired from Apollon Formularies, plc ("Apollon") earlier this year.

Nagel 先生是天然生物製劑藥物發現和製造領域的資深人士,在該行業擁有超過 15 年的經驗。他帶來了豐富的知識和專業知識,這些知識和專業知識對於 Global H麻Group Inc. 無論是擔任研發部門的顧問,以及協助管理層與各種製造商和分銷商進行繼續討論,從 Apollon Proicaries 獲得的各種大麻製造商和分銷商今年早些時候獲得的專利和知識產權的獨家許可。

Jeff is currently Vice-President and Director of Medical Product Development at Apollon Formularies plc and was responsible for the production and manufacturing of all of the Apollon products demonstrated to be successful in killing breast and prostate cancer cells in Apollon's preclinical independent testing at BIOENSIS laboratories and currently sold by physician prescription in Jamaica. He was also responsible for manufacturing all of the natural biologics based medical products for the cancer clinical trials.

Jeff 目前是 Apollon 處方集 plc 的醫療產品開發副總裁兼總監,負責生產和製造所有 Apollon 產品,證明在阿波隆的臨床前獨立測試中成功殺死乳腺癌和前列腺癌細胞,目前由牙買加的醫生處方出售。他還負責製造所有用於癌症臨床試驗的天然生物製劑醫療產品。

In the event that GHG exercises its option to acquire the entirety of the Apollon assets per the binding Letter of Intent executed between the Parties (for further detail on the transaction, see the news release of January 11, 2023 and March 20, 2023), the Company will look to bring on Mr. Nagel as its Vice-President and Director of Global Manufacturing ("DGM"). As VP and DGM Jeff's role will be to oversee the Company's global manufacturing operations of the Apollon products, including product development, quality control, and supply chain management, and work closely with the Company's executive team to develop and execute manufacturing strategies that align with the company's overall goals and objectives.

如果溫室氣體按照雙方之間執行的約束性意向書(有關交易的進一步詳細信息,請參閱 2023 年 1 月 11 日和 2023 年 3 月 20 日的新聞稿),公司將聘請 Nagel 先生擔任其副總裁兼全球製造總監(「DGM」)。作為副總裁兼 DGM Jeff 的職責將是監督公司 Apollon 產品的全球製造業務,包括產品開發、品質控制和供應鏈管理,並與公司的執行團隊密切合作,制定和執行符合公司整體目標和目標的製造策略。

"I am excited to join the team at Global Hemp Group, Inc. and contribute to the growth and success of the company," said Nagel. "I believe that the recent exclusive intellectual property licenses procured from Apollon opens the door for the creation of some amazing and innovative new products in the natural biologics space!"

Nagel 說:「我很高興能加入全球大麻集團公司的團隊,並為公司的成長和成功做出貢獻。」「我相信,最近從 Apollon 購買的獨家知識產權許可證為在天然生物製劑領域創造一些令人驚嘆且創新的新產品打開了大門!」

"Jeff's extensive experience and expertise in manufacturing and product formulation will greatly assist the Company as it talks to manufacturers and distributors about sublicensing and monetizing GHG's exclusive licenses from Apollon" said Stephen Barnhill, Jr, Interim CEO of Global Hemp Group, Inc. "We are thrilled to have him on board and look forward to working with him to take this segment of our business to the next level."

「傑夫在製造和產品配方方面的豐富經驗和專業知識將極大地幫助該公司,因為它與製造商和分銷商談論了阿波隆 GHG 獨家許可證的再授權和貨幣化」斯蒂芬·巴恩希爾(Stephen Barnhill)表示,Jr,全球大麻集團公司臨時首席執行官「我們很高興有他加入,並期待與他合作將我們的業務部門提升到下一個水平。」

About Global Hemp Group Inc.

關於全球大麻集團公司.

Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is focused on developing and promoting hemp-based products that are sustainable, environmentally friendly, and have a positive impact on society. To further support and innovate, GHG has established a R&D Division to actively pursue the development of Intellectual Property that can be patented for implementation at its projects and beyond. The Division is led by Prof. Víctor M. Castaño, Ph.D. whose career has focused in the areas of applied science and technology. The R&D team is initially focused on development of Environmentally Friendly Construction Materials, Nanofertilizers and Enhanced Cannabinoid Extraction from Hemp.

全球大麻集團公司(CSE:GHG)(場外粉紅色:GBHPF)(FSE:GHG)致力於開發和推廣可持續,環保且對社會產生積極影響的大麻產品。為了進一步支持和創新,溫室氣體建立了一個研發部門,積極追求知識產權的發展,這些知識產權可以獲得專利,以便在其項目及其後實施。該部門由 Victor M. Castano 博士領導,他的職業生涯專注於應用科學和技術領域。研發團隊最初專注於開發環保建築材料,納米肥料和增強大麻素從大麻提取。

Subscribe to the GHG YouTube Channel:

訂閱溫室氣體的 YouTube 頻道:

Like us on Facebook:

在臉書上讚好我們:

Follow us on Instagram:

在 Instagram 上關注我們:

Follow us on Twitter:

在推特上關注我們:

Connect with us on LinkedIn:

在領英上與我們聯繫:

For Further Information Contact Global Hemp Group

有關更多信息,請聯繫全球麻集團

Investor Relations

投資者關係

Tel: 778-726-2900

電話:778-726-2900

info@globalhempgroup.com

info@globalhempgroup.com

Cautionary Note Regarding Forward Looking Statements

關於前瞻性陳述的注意事項

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to, the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, and the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of Page 2 of 2 preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

本新聞稿所載的若干資料可能包含前瞻性陳述,涉及重大的已知及未知風險及不確定因素。這些前瞻性陳述受到許多風險和不確定性的影響, 其中某些風險和不確定性超出了 Global H麻Group Inc. 的控制範圍, 包括但不限於, 一般經濟狀況的影響, 行業狀況, 商品價格的波動, 貨幣波動, 對監管機構批准的依賴性, 未來的融資和勘探風險的可用性, 以及大麻和大麻的合法性.讀者請注意,在編製該等資料時所採用的假設,雖然在準備第 2 頁的第 2 頁時被認為是合理的,但可能被證明不精確,因此,不應將不當的依賴置於前瞻性陳述中。除法律要求外,Global Hhemp Group Inc. 拒絕任何意圖,並且沒有義務更新或修改任何前瞻性聲明以反映實際結果,無論是由於新信息,未來事件,假設變化,影響此類前瞻性陳述的因素的變化或其他原因。

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

CSE 沒有審查,也不對此版本的充分性或準確性承擔責任。

To view the source version of this press release, please visit

如欲查看此新聞稿的來源版本,請瀏覽

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論